跳至主要内容
临床试验/NCT06086652
NCT06086652招募中不适用

Role of Positron Emission Tomography in Detecting Primary Tumor in Cases of Metastases of Unknown Origin

Sohag University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1
主要终点
primary tumor for metastasis of unknown origin

研究概览

简要总结

In most cases of malignancies, the site of origin of the cancer is clear at presentation or identified soon after. However, Metastatic cancer of unknown primary site (MUO) accounts for 3-5% of all malignant neoplasms, and it is defined as metastatic cancer from an unknown primary site, for which no original site can be detected even after performing all possible tests. Most common metastatic sites include the liver, lymph nodes, lungs, and bones.

18F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) allows whole-body tumor detection and has proven to be useful in patients with metastasis of unknown primary tumor.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years Patients with metastatic tumor. Primary site was not detected with other radiological examinations Both male and female.

排除标准

  • Patients with known primary tumor Pregnancy. Age < 18 years.

结局指标

主要结局

primary tumor for metastasis of unknown origin

时间窗: one month

primary tumor for metastasis of unknown origin

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doaa Ibrahim Mohamed

lecturer of nuclear medicine, faculty of medicine, Sohag university

Sohag University

研究点 (1)

Loading locations...

相似试验

Role of Positron Emission Tomography in Detecting... | 临床试验